Array Biopharma, Inc. (ARRY) Reports Q2 Loss of 17c/Share
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $5.05 -2.32%
Financial Fact:
Interest expense: -2.98M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Interest expense: -2.98M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Array Biopharma, Inc. (NASDAQ: ARRY) reported Q2 EPS of ($0.17), $0.10 better than the analyst estimate of ($0.27).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
